Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00506

Submission Number:
00506
Commenter:
Gabriel Guijarro
State:
Texas
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
As an owner of an independent Community Retail Pharmacy for the past 30 years the emergence of PBM's and the mergers that have been allowed to occur have been detrimental to the patients we serve as well as to small businesses such as mine. I oppose the merger between CVS and Aetna and appeal to the FTC to block the merger.